Toca 511 and Toca FC in patients with gastrointestinal tumors in the Toca 6 study.

被引：0
|
作者：
Merchan, Jaime R.
Ostertag, Derek
Jolly, Douglas J.
Tejera, Dalissa
Gruber, Harry E.
Shorr, Jolene
机构：
[1] Univ Miami, Miami, FL USA
[2] Tocagen Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.TPS880
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS880
引用
收藏
页数：1
相关论文
共 50 条
  • [31] NRG ONCOLOGY NRG-BN006: A PHASE II/III RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 AND TOCA FC WITH STANDARD OF CARE COMPARED TO STANDARD OF CARE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Ahluwalia, Manmeet
    Pugh, Stephanie
    Ellingson, Benjamin
    Kotecha, Rupesh
    Cloughesy, Timothy
    Vogelbaum, Michael
    Aldapec, Kenneth
    Cu, Yunfeng
    Armstrong, Terri
    Mehta, Minesh
    NEURO-ONCOLOGY, 2019, 21 : 220 - 221
  • [32] ADMINISTRATION OF TOCA 511 TO SUBJECTS WITH RECURRENT HGG UNDERGOING REPEAT RESECTION
    Cloughesy, Timothy F.
    Kesari, Santosh
    Kalkanis, Steven
    Mikkelsen, Tom
    Landolfi, Joseph
    Elder, J. Bradley
    Liau, Linda M.
    Chen, Clark C.
    Bloomfield, Stephen
    Piccioni, David
    Chiocca, E. Antonio
    Foltz, Greg
    Robbins, Joan M.
    Ostertag, Derek
    Jolly, Doug J.
    Ibanez, Carlos
    Pertschuk, Dan
    Pan, Christine
    Vogelbaum, Michael A.
    NEURO-ONCOLOGY, 2014, 16
  • [33] COMPLEMENTARY CLINICAL AND ANCILLARY DATA FROM 123 PATIENTS WITH RECURRENT HIGH GRADE GLIOMA FROM THREE PHASE 1 TRIALS OF TOCA 511 AND TOCA FC: UPDATE AND JUSTIFICATION FOR A PHASE 2/3 TRIAL
    Aghi, Manish
    Vogelbaum, Michael
    Kalkanis, Steven
    Bota, Daniela
    Carter, Bob
    Chen, Clark
    Elder, Bradley
    Engh, Johnathan
    Goldlust, Samuel
    Kaptain, George
    Kesari, Santosh
    Landolfi, Joseph
    Liau, Linda
    Mikkelsen, Tom
    Piccioni, David
    Portnow, Jana
    Singer, Samuel
    Walbert, Tobias
    Gruber, Harry
    Ibanez, Carlos
    Jolly, Douglas
    Mitchell, Leah
    Ostertag, Derek
    Shorr, Jolene
    Yang, Liqiang
    Das, Asha
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2016, 18 : 18 - 18
  • [34] Administration of Toca 511 to subjects with recurrent HGG undergoing repeat resection
    Vogelbaum, Michael A.
    Cloughesy, Timothy
    Landolfi, Joseph
    Mikkelsen, Tom
    Elder, J. Bradley
    Kesari, Santosh
    Cobbs, Charles
    Skillings, Jamey
    Jolly, Douglas
    Robbins, Joan
    Ostertag, Derek
    Ibanez, Carlos
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (03) : 619 - 619
  • [35] Molecular Analyses Support the Safety and Activity of Retroviral Replicating Vector Toca 511 in Patients
    Hogan, Daniel J.
    Zhu, Jay-Jiguang
    Diago, Oscar R.
    Gammon, Dawn
    Haghighi, Ali
    Lu, Guangrong
    Das, Asha
    Gruber, Harry E.
    Jolly, Douglas J.
    Ostertag, Derek
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4680 - 4693
  • [36] Immune profile of tumor microenvironment helps predict response in patients treated with an investigational immunotherapeutic consisting of a retroviral replicating vector (Toca 511) and an extended-release formulation of 5-fluorocytosine (Toca FC)
    Ostertag, Derek
    Accomando, William
    Mitchell, Leah
    Rodriguez-Aguirre, Maria
    Hogan, Daniel
    Diago, Oscar
    Gammon, Dawn
    Haghighi, Ali
    Gruber, Harry
    Das, Asha
    Jolly, Douglas
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer
    Collins, Sara A.
    Shah, Ashish H.
    Ostertag, Derek
    Kasahara, Noriyuki
    Jolly, Douglas J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1199 - 1214
  • [38] Long-Term Follow-Up Data from 126 Patients with Recurrent High Grade Glioma from Three Phase 1 Trials of Toca 511 and Toca FC: Update and Justification for a Phase 2/3 Trial
    Jolly, Doug J.
    Aghi, Manish
    Vogelbaum, Michael A.
    Kalkanis, Steven N.
    Bota, Daniela
    Chen, Clark C.
    Carter, Bob
    Elder, Brad
    Engh, Johnathan
    Goldlust, Samuel A.
    Kaptain, George J.
    Kesari, Santosh
    Landolfi, Joseph
    Liau, Linda M.
    Mikkelsen, Tom
    Piccioni, David
    Portnow, Jana
    Singer, Samuel
    Walbert, Tobias
    Gruber, Harry
    Ibanez, Carlos
    Mitchell, Leah
    Ostertag, Derek
    Shorr, Jolene S.
    Yang, Liqiang
    Das, Asha
    Cloughesy, Timothy F.
    MOLECULAR THERAPY, 2017, 25 (05) : 24 - 25
  • [39] LONG-TERM FOLLOW-UP DATA FROM 126 PATIENTS WITH RECURRENT HIGH GRADE GLIOMA FROM THREE PHASE 1 TRIALS OF TOCA 511 AND TOCA FC: UPDATE AND JUSTIFICATION FOR A PHASE 2/3 TRIAL
    Aghi, M.
    Vogelbaum, M. A.
    Kalkanis, S. N.
    Bota, D.
    Piccioni, D.
    Elder, B.
    Engh, J.
    Kaptain, G. J.
    Landolfi, J.
    Cloughesy, T. F.
    NEURO-ONCOLOGY, 2017, 19 : 19 - 19
  • [40] Long-term follow-up data from 123 patients with recurrent high grade glioma from three Phase 1 trials of Toca 511 and Toca FC: Update and justification for a Phase 2/3 trial
    Huang, Tiffany T.
    Aghi, Manish
    Vogelbaum, Michael
    Kalkanis, Steven
    Bota, Daniela
    Carter, Bob
    Chen, Clark
    Elder, Bradley
    Kaptain, George
    Kesari, Santosh
    Cloughesy, Timothy
    Walbert, Tobias
    JOURNAL OF NEUROSURGERY, 2017, 126 (04) : A1414 - A1414
12345